Wordt geladen...
Selective gene amplification to detect the T790M mutation in plasma from patients with advanced non-small cell lung cancer (NSCLC) who have developed epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) resistance
BACKGROUND: The epidermal growth factor receptor (EGFR) T790M mutation is associated with resistance to EGFR tyrosine kinase inhibitors (EGFR-TKIs) in non-small cell lung cancer (NSCLC). However, tissues for the genotyping of the EGFR T790M mutation can be difficult to obtain in a clinical setting....
Bewaard in:
| Gepubliceerd in: | J Thorac Dis |
|---|---|
| Hoofdauteurs: | , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
AME Publishing Company
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5906242/ https://ncbi.nlm.nih.gov/pubmed/29707292 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2018.01.144 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|